Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, announced its financial results for the first quarter ended June 30 of financial year 2018-19. For the...
Net profit of Bal Pharma rose 229.58% to Rs 2.34 crore in the quarter ended June 2018 as against Rs 0.71 crore during the previous quarter...
The weightage of the pharmaceutical sector on the Nifty index is likely to drop to levels last seen after the Lehman crisis, analysts at ICICI Securities...
Akums Drugs and Pharmaceuticals Ltd., one of India’s largest Contract Drug Research and Manufacturing Organizations (CRAMS), has won the prestigious Business Leadership Award at the National...
India’s second largest drug manufacturer Aurobindo Pharmais likely to report a net profit of Rs 539 .5 crore for the first quarter of FY19, going by an...
Pharma Major Lupin Limited reported its financial performance for the first quarter ending June 30th, 2018. These results were taken on record by the Board of...
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the U.S. Food & Drug Administration (FDA) has accepted for review the company’s New Drug Application for...
Cipla Limited announced its unaudited consolidated financial results for quarter ended June 30, 2018. Key highlights of the quarter: Financials: Strong YoY sales growth of 12% with...
Glenmark Pharmaceuticals’ partner Elite Pharmaceuticals has received approval from the U. S. Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) for methadone hydrochloride 5 mg and 10 mg tablets. Methadone is...
Kilitch Drugs (India) Ltd, a fast growing pharmaceuticals company listed on NSE and BSE, today announced its plans to focus on African markets with a state-of-the-art...
On August 08, 2018, Peter Koerte, President – Point-of-Care Diagnostics, Siemens Healthineers, inaugurated the new diagnostics manufacturing facility at Vadodara, Gujarat. The new state-of-the-art facility is spread across 3150...
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) today announced that Sun Pharma...
Cipla Limited (“Cipla”) announced that it has received final approval on August 3, 2018, for its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel,...
Drug firm Unichem Laboratories today said the US health regulator has made four observations after inspection of its active pharmaceutical ingredient (API) manufacturing facility at Roha in Maharashtra. The Roha...
Glenmark Pharmaceuticals S.A. and Harbour BioMed, announced that they have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize...
Copyright © 2024 Medical Buyer